Application YC di Rejuvenation Technologies Inc.

Summer 2018Active

Rejuvenation Technologies Inc. ha partecipato a Y Combinator nel batch Summer 2018 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2018
Settore: HealthcareTherapeutics
Dimensione team: 2
Stato: Active
Lanciata: 2018

Founder

Glenn MarkovFounder
John RamunasFounder

Cosa fa Rejuvenation Technologies Inc.

Stanford-patented essential drug platform unlocks the healthspan, which is limited by short telomeres. Extends mouse lifespan by equivalent of 10 years in humans. Reverses 5-10 years of telomere shortening with one dose in one day. Preclinical efficacy in 4 organ systems including immune system. Entering clinical stage. CEO is Subject #1 in longevity trial. 50+ granted patents, 7 patent families. FDA INTERACT cleared. Raising $10M seed extension ($2M+ wired) to fund 3 investigator-initiated trials. Readouts in Q3 2027. $6.8B in comparable mRNA-LNP M&A in last 12 months.

Application YC di Rejuvenation Technologies Inc., ricostruita

Domanda per Y Combinator

Rejuvenation Technologies Inc., batch Summer 2018. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rejuvenation Technologies Inc.

Describe what your company does in 50 characters or less.

mRNA therapeutics to extend healthspan

What is your company going to make? Please describe your product and what it does or will do.

We develop an mRNA drug platform that extends healthspan by reversing telomere shortening. Our therapy extends mouse lifespan by the human equivalent of 10 years with a single dose, showing efficacy in multiple organ systems, including the immune system. We are entering clinical trials to validate this approach in humans, addressing the root cause of aging linked to short telomeres.

Where do you live now, and where would the company be based after YC?

We live and work in San Francisco, CA, and plan to base the company here after YC as well.

Explain your decision regarding location.

San Francisco offers the right ecosystem of biotech expertise, funding, and clinical trial access. Being where the science and capital meet is necessary for our clinical-stage gene therapy startup.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Rejuvenation Technologies Inc.?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Rejuvenation Technologies Inc. (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Rejuvenation Technologies Inc. si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. apparteneva al batch Summer 2018 di Y Combinator.

Chi ha fondato Rejuvenation Technologies Inc.?

Rejuvenation Technologies Inc. è stato fondato da Glenn Markov, John Ramunas.

Cosa fa Rejuvenation Technologies Inc.?

mRNA therapeutics to extend healthspan entering clinical trials

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Rejuvenation Technologies Inc., e di ogni altro batch YC, è in YC Insights.